NCT00557583View on ClinicalTrials.gov

Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Chronic Hepatitis C Infection
Interventions
DRUG

VBY 376

Doses of 50mg and higher or placebo will be evaluated.

Trial Locations (1)

53704

Covance Clinical Research Unit, Madison

All Listed Sponsors
lead

Virobay Inc.

INDUSTRY

NCT00557583 - Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults | Biotech Hunter | Biotech Hunter